-
1
-
-
0032948381
-
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas
-
Achiwa H, Yatabe Y, Hida T, et al (1999). Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res, 5, 1001-5 .
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1001-1005
-
-
Achiwa, H.1
Yatabe, Y.2
Hida, T.3
-
2
-
-
0042631411
-
Celecoxib,a selective cyclo-oxygenase-2 infibitor,enhances the response to preoperative paclitaxel and carboplatin in early-stage non small cell lung cancer
-
Altorki NK, Keresztes RS, Port JL, et al (2003). Celecoxib,a selective cyclo-oxygenase-2 infibitor,enhances the response to preoperative paclitaxel and carboplatin in early-stage non small cell lung cancer. J Clin Oncol, 21, 2645-50.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2645-2650
-
-
Altorki, N.K.1
Keresztes, R.S.2
Port, J.L.3
-
3
-
-
0036191910
-
Prognostic significance of cyclooxygenase 2 mRNA expression in non small cell lung cancer
-
Brabender J, Park J, Metzger R, et al (2002). Prognostic significance of cyclooxygenase 2 mRNA expression in non small cell lung cancer. Ann Surg, 235, 440-3.
-
(2002)
Ann Surg
, vol.235
, pp. 440-443
-
-
Brabender, J.1
Park, J.2
Metzger, R.3
-
4
-
-
0141562299
-
Lung cancer and cyclooxygenase-2
-
Castelao JE, Bart RD 3rd, DiPerna CA, et al (2003). Lung cancer and cyclooxygenase-2. Ann Thorac Surg, 76, 1327-35.
-
(2003)
Ann Thorac Surg
, vol.76
, pp. 1327-1335
-
-
Castelao, J.E.1
Bart, R.D.2
DiPerna, C.A.3
-
5
-
-
0036124320
-
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carsinoma
-
Denkert C, Köbel M, Pest S, et al (2002). Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carsinoma. Am J Pathol, 160, 893-903.
-
(2002)
Am J Pathol
, vol.160
, pp. 893-903
-
-
Denkert, C.1
Köbel, M.2
Pest, S.3
-
6
-
-
0031416517
-
Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice
-
Duperron C, Castonguay A (1997). Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carsinogenesis, 18, 1001-6.
-
(1997)
Carsinogenesis
, vol.18
, pp. 1001-1006
-
-
Duperron, C.1
Castonguay, A.2
-
7
-
-
39749149266
-
Eicosanoid modulation in advenced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy-Cancer and Leukemia Group B Trial 30203
-
Edelman MJ, Watson D, Wang X, et al(2008). Eicosanoid modulation in advenced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy-- Cancer and Leukemia Group B Trial 30203. J Clin Oncol, 26, 848-55.
-
(2008)
J Clin Oncol
, vol.26
, pp. 848-855
-
-
Edelman, M.J.1
Watson, D.2
Wang, X.3
-
8
-
-
42249111036
-
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinid and celecoxib
-
Fidler MJ, Argiris A, Patel JD, et al (2008). The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinid and celecoxib. Clin Cancer Res, 14, 2088-94.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2088-2094
-
-
Fidler, M.J.1
Argiris, A.2
Patel, J.D.3
-
9
-
-
0036632411
-
Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers
-
Harris RE, Beebe-Donk J, Schuller HM (2002). Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep, 9, 693-5.
-
(2002)
Oncol Rep
, vol.9
, pp. 693-695
-
-
Harris, R.E.1
Beebe-Donk, J.2
Schuller, H.M.3
-
10
-
-
0034026144
-
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
-
Hida T, Kozaki K, Muramatsu H, et al (2000). Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res, 6, 2006-11.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2006-2011
-
-
Hida, T.1
Kozaki, K.2
Muramatsu, H.3
-
11
-
-
0032170955
-
Incresed expression of cyclooxygenase 2 occurs frequently in human lung cancers , specifically in adenocarsinomas
-
Hida T, Yatabe Y, Achiwa H, et al (1998). Incresed expression of cyclooxygenase 2 occurs frequently in human lung cancers , specifically in adenocarsinomas. Cancer Res, 58, 3761-4.
-
(1998)
Cancer Res
, vol.58
, pp. 3761-3764
-
-
Hida, T.1
Yatabe, Y.2
Achiwa, H.3
-
12
-
-
0034901568
-
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non small cell lung cancer
-
Khuri FR, Wu H, Lee JJ, et al (2001). Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non small cell lung cancer. Clin Cancer Res, 7, 861-7.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 861-867
-
-
Khuri, F.R.1
Wu, H.2
Lee, J.J.3
-
13
-
-
0034161878
-
Antiangigenic and antitumor activities of cyclooxygenase-2 inhibitors
-
Masferrer JL, Leahy KM, Koki AT, et al (2000). Antiangigenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 60, 1306-11.
-
(2000)
Cancer Res
, vol.60
, pp. 1306-1311
-
-
Masferrer, J.L.1
Leahy, K.M.2
Koki, A.T.3
-
14
-
-
33745929929
-
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
-
Mascaux C, Martin B, Paesmans M, et al (2006). Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results. Br J Cancer, 9, 139-45.
-
(2006)
Br J Cancer
, vol.9
, pp. 139-145
-
-
Mascaux, C.1
Martin, B.2
Paesmans, M.3
-
15
-
-
0034488632
-
Nitric oxide synthase, cyclooxigenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma
-
Marrogi AJ, Travis WD, Welsh JA, et al (2000). Nitric oxide synthase, cyclooxigenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res, 6, 4739-44.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4739-4744
-
-
Marrogi, A.J.1
Travis, W.D.2
Welsh, J.A.3
-
16
-
-
0034161878
-
Antiangigenic and antitumor activities of cyclooxygenase-2 inhibitors
-
Masferrer JL, Leahy KM, Koki AT, Zweifel BS, et al (2000). Antiangigenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 60, 1306-11.
-
(2000)
Cancer Res
, vol.60
, pp. 1306-1311
-
-
Masferrer, J.L.1
Leahy, K.M.2
Koki, A.T.3
Zweifel, B.S.4
-
17
-
-
0036189825
-
Staging classşfication of lung cancer. A critical evaluation
-
Mountain CF (2002). Staging classşfication of lung cancer. A critical evaluation. Clin Chest Med, 23, 103-21.
-
(2002)
Clin Chest Med
, vol.23
, pp. 103-121
-
-
Mountain, C.F.1
-
18
-
-
0033199927
-
Enhancemant of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme
-
Milas L, Kishi K, Hunter N, et al (1999). Enhancemant of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst, 91, 1501-4.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1501-1504
-
-
Milas, L.1
Kishi, K.2
Hunter, N.3
-
19
-
-
0036283215
-
Cyclooxygenase, lipoxygenase and tumor angiogenesis
-
Nie D, Honn KV (2002). Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci, 59, 799-807.
-
(2002)
Cell Mol Life Sci
, vol.59
, pp. 799-807
-
-
Nie, D.1
Honn, K.V.2
-
20
-
-
4444305435
-
Elevated cyclooxygenase-2 expression correlates with distant metastates in breast cancer
-
Ranger GS, Thomas V, Jewell A, et al (2004). Elevated cyclooxygenase-2 expression correlates with distant metastates in breast cancer. Anticancer Res, 24, 2349-51.
-
(2004)
Anticancer Res
, vol.24
, pp. 2349-2351
-
-
Ranger, G.S.1
Thomas, V.2
Jewell, A.3
-
21
-
-
0036468899
-
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
-
Ristimäki A, Sivula A, Lundin J, et al (2002). Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res, 62, 632-5.
-
(2002)
Cancer Res
, vol.62
, pp. 632-635
-
-
Ristimäki, A.1
Sivula, A.2
Lundin, J.3
-
22
-
-
0028325496
-
Aspirin use and lung, colon and breast cancer incidence in a prospective study
-
Schreinemachers DM, Everson RB (1994). Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology, 5, 138-46.
-
(1994)
Epidemiology
, vol.5
, pp. 138-146
-
-
Schreinemachers, D.M.1
Everson, R.B.2
-
23
-
-
1242314857
-
Role of cyclooxygenase-2 in colorectal cancer
-
Sinicrope FA, Gill S (2004). Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev, 23, 63-75.
-
(2004)
Cancer Metastasis Rev
, vol.23
, pp. 63-75
-
-
Sinicrope, F.A.1
Gill, S.2
-
24
-
-
0034971264
-
Why there are two cyclooxygenase isozymes
-
Smith WL, Langenbach R (2001). Why there are two cyclooxygenase isozymes. J Clin Invest, 107, 1491-5.
-
(2001)
J Clin Invest
, vol.107
, pp. 1491-1495
-
-
Smith, W.L.1
Langenbach, R.2
-
25
-
-
0037108880
-
Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11
-
Trifan OC, Durham WF, Salazar VS, et al (2002). Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT- 11. Cancer Res, 62, 5778-84.
-
(2002)
Cancer Res
, vol.62
, pp. 5778-5784
-
-
Trifan, O.C.1
Durham, W.F.2
Salazar, V.S.3
-
27
-
-
33748744068
-
Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in non-small cell lung cancer
-
Tsubochi H, Sato N, Hiyama M, et al (2006). Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in non-small cell lung cancer. Ann Thorac Surg, 82, 1198-204.
-
(2006)
Ann Thorac Surg
, vol.82
, pp. 1198-1204
-
-
Tsubochi, H.1
Sato, N.2
Hiyama, M.3
-
28
-
-
0034525705
-
Inhibition of COX-2 and induction of apoptosis: two determinants of antiinflammatory drugs chemopreventive efficacies in mouse lung tumorigenesis
-
Yao R, Rioux N, Castonguay A, et al (2000). Inhibition of COX-2 and induction of apoptosis: two determinants of antiinflammatory drugs chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res, 26, 731-42.
-
(2000)
Exp Lung Res
, vol.26
, pp. 731-742
-
-
Yao, R.1
Rioux, N.2
Castonguay, A.3
-
29
-
-
0032893269
-
Cyclooxygenase-2 expresion in human esophageal carsinoma
-
Zimmermann KC, Sarbia M, Weber AA, et al (1999). Cyclooxygenase-2 expresion in human esophageal carsinoma. Cancer Res, 59, 198-204.
-
(1999)
Cancer Res
, vol.59
, pp. 198-204
-
-
Zimmermann, K.C.1
Sarbia, M.2
Weber, A.A.3
|